Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey. (PubMed, J Assoc Physicians India) - Oct 24, 2026 - "Biosimilars could enhance equity, but require robust data and regulation. Targeted education, reimbursement policies, and region-specific evidence are essential to optimize AOM integration in obesity management."
Journal • Genetic Disorders • Metabolic Disorders • Obesity
|
|
Abm Kamrul-Hasan; Aswin Pankaj; Dina Shreshtha; Khushboo Agarwal; Lakshmi Nagendra; Musarrat Riaz; Nitin Kapoor; Rucha Mehta; Sambit Das; Sanjay Kalra; Saptarshi Bhattacharya; Shehla Sheikh; Sourabh Sharma
|